Understanding iDose® TR: A Breakthrough in Glaucoma Treatment thumbnail

Understanding iDose® TR: A Breakthrough in Glaucoma Treatment

Published Nov 30, 24
1 min read


iDose® TR marks a significant breakthrough in the treatment of glaucoma, offering a long-term and efficient method for managing intraocular pressure (IOP). Unlike traditional eye drops that need to be applied every day, iDose® TR is a tiny, implantable device crafted to provide a controlled dispensation of treatment directly into the eye over an longer period. This groundbreaking approach removes the hassle of daily applications, dramatically boosting patient adherence and overall treatment results.

At Eye Center South, we are proud to offer iDose® TR as part of our comprehensive glaucoma care. The device is placed during a simple and low-risk procedure, ensuring patient comfort and convenience. Once in place, it provides a steady release of glaucoma medication, working to stabilize intraocular pressure and protect your vision. Patients who have difficulty managing the challenges of daily eye drop regimens can benefit greatly from this state-of-the-art treatment.



Visit for more info At Eye Center South